Clinical Trial: Pilot Study of Abequolixron (RGX-104) and Durvalumab in Lung Cancer
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Non-Small Cell Lung Cancer
Study Type: INTERVENTIONAL
Official Title: A Pilot Window of Opportunity Study Evaluating Durvalumab (MEDI4736) in Combination With Platinum Doublet Chemotherapy Followed by Evaluation of Durvalumab (MEDI4736) in Combination With Platinum Doub
Brief Summary:
Non-Small Cell Lung Cancer (NSCLC) is one of the deadliest types of cancer.In lung cancer patients with a tumor that can be removed by surgery, adjuvant chemotherapy increases survival.Neoadjuvant therapy may have advantages such as, it may be more tolerable prior to surgery, earlier treatment may be more efficacious, and it can provide an indication of treatment response.Neoadjuvant treatment can provide pre- and post-treatment specimens for correlative analysis to better understand mechanisms of action and…
Read more